International Vaccine Institute
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ivi.int
Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants
Phase 2
Terminated
- Conditions
- DiarrheaVibrio InfectionsCholera
- Interventions
- Biological: PlaceboBiological: Peru-15 Vaccine
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 74
- Registration Number
- NCT00624975
- Locations
- 🇮🇳
Christian Medical College, Vellore, India
🇧🇩International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Phase 2
- Conditions
- CholeraVibrio InfectionsDiarrhea
- Interventions
- Biological: Killed Escherichia coli K12 placeboBiological: Bivalent killed oral cholera vaccine
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 300
- Registration Number
- NCT00548054
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Disease, Kolkata, West Bengal, India
Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
Phase 2
Completed
- Conditions
- CholeraDiarrheaVibrio Infections
- Interventions
- Biological: Killed bivalent whole cell oral cholera vaccineBiological: Heat Killed E. coli Placebo
- First Posted Date
- 2007-01-08
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 160
- Registration Number
- NCT00419133
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
Phase 3
Completed
- Conditions
- CholeraDiarrheaVibrio Infections
- Interventions
- Biological: bivalent killed whole cell oral cholera vaccineBiological: Placebo
- First Posted Date
- 2006-02-09
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 69329
- Registration Number
- NCT00289224
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Phase 4
Completed
- Conditions
- TyphoidParatyphoid Fever
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2008-03-13
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 100742
- Registration Number
- NCT00131820
- Locations
- 🇻🇳
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Phase 4
Completed
- Conditions
- TyphoidParatyphoid Fever
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2008-03-13
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 96468
- Registration Number
- NCT00131833
- Locations
- 🇨🇳
Hechi City Center for Disease Control, Hechi City, Guangxi, China
Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine
Phase 2
Completed
- Conditions
- Cholera
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2006-11-10
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 150
- Registration Number
- NCT00128011
- Locations
- 🇻🇳
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Phase 4
Completed
- Conditions
- TyphoidParatyphoid Fever
- Interventions
- Biological: Hepatitis A vaccineBiological: Typhoid Vi vaccine
- First Posted Date
- 2005-07-29
- Last Posted Date
- 2008-08-26
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 37673
- Registration Number
- NCT00125008
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Phase 4
Completed
- Conditions
- TyphoidParatyphoid Fever
- Interventions
- Biological: Hepatitis A vaccineBiological: Typhoid Vi vaccine
- First Posted Date
- 2005-07-29
- Last Posted Date
- 2008-08-26
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 27231
- Registration Number
- NCT00125047
- Locations
- 🇵🇰
Aga Khan University, Karachi, Pakistan
Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
Phase 2
Completed
- Conditions
- Cholera
- Interventions
- Biological: killed whole cell oral cholera vaccineBiological: Heat Killed E. coli
- First Posted Date
- 2005-07-13
- Last Posted Date
- 2008-07-04
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 200
- Registration Number
- NCT00119197
- Locations
- 🇮🇳
National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
© Copyright 2025. All Rights Reserved by MedPath